The alternated expression of distinct RASSF1 isoforms with opposing functions would explain the association between loss of RASSF1A expression and an adverse outcome and disease progression for certain cancer types, calling upon the need of more functional studies to better understand the functional consequence of this switch. This evidence concerns the gene RASSF1 and cancer.